G1 Therapeutics begins Phase I clinical trial of G1T28-1 for several oncology indications
The trial is designed to evaluate the safety, pharmacokinetics and pharmacodynamics of G1T28-1 in healthy volunteers, who are currently being enrolled in the Netherlands. The company is conducting